Masimo Corporation

NasdaqGS:MASI

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

🌐 Internet of Things (IoT)

💻 Telehealth

Location

United States

Market Cap

USD 9.23 B

Share Price

USD 169.30

Avg Daily Volume

657,446

Change (1 day)

-0.57%

Change (1 year)

27.84%

Change (YTD)

2.42%

Masimo Corporation Revenue for the Trailing 12 Months (TTM) ending March 29, 2025: USD 1.97 B

Masimo Corporation Revenue is USD 1.97 B for the Trailing 12 Months (TTM) ending March 29, 2025, a -0.12% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Masimo Corporation Revenue for the Trailing 12 Months (TTM) ending March 30, 2024 was USD 1.98 B, a -13.96% change year over year.
Masimo Corporation Revenue for the Trailing 12 Months (TTM) ending April 01, 2023 was USD 2.30 B, a 84.56% change year over year.
Masimo Corporation Revenue for the Trailing 12 Months (TTM) ending April 02, 2022 was USD 1.24 B, a 6.07% change year over year.
Masimo Corporation Revenue for the Trailing 12 Months (TTM) ending April 03, 2021 was USD 1.17 B, a 20.23% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Revenue	Revenue	Gross Profit	Operating Income

NasdaqGS: MASI

Masimo Corporation

CEO	Ms. Catherine M. Szyman
IPO Date	Aug. 8, 2007
Location	United States
Headquarters	52 Discovery
Employees	3,600
Sector	🏥 Health Care
Industries Medical Instruments 🌐 Internet of Things (IoT) 💻 Telehealth

Description

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.